Intrinsic Value of S&P & Nasdaq Contact Us

Illumina, Inc. ILMN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
61/100
4/7 Pass
SharesGrow Intrinsic Value
$143.90
+10.4%
Analyst Price Target
$147.13
+12.9%

Illumina, Inc. (ILMN) has a consensus analyst rating of Buy, based on 50 analysts covering the stock. Of those, 25 recommend buying, 19 recommend holding, and 6 recommend selling.

The analyst consensus price target for ILMN is $147.13, representing a +12.9% upside from the current price of $130.32. Price targets range from a low of $110.00 to a high of $170.00.

Analyst Consensus — ILMN

Buy
Strong Buy
1
Buy
24
Hold
19
Sell
6
Strong Sell
0
50 analysts
Price Targets
Consensus$147.13
High$170.00
Low$110.00
Median$150.00
Last Month Avg-
Last Quarter Avg$152.43
Last Year Avg$130.36
All-Time Count64
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message